120 related articles for article (PubMed ID: 38902561)
1. Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.
Zhang S; Patel K; Dusenbery K; Alshreef A; Sterling D; Sloan L; Reynolds M; Chen CC; Ferreira C
J Neurooncol; 2024 Jun; ():. PubMed ID: 38902561
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric Impact of Source Displacement in GammaTile Surgically Targeted Radiation Therapy for Gliomas.
Ng SK; Yue Y; Shiue K; Shah MV; Le Y
Cureus; 2023 May; 15(5):e38463. PubMed ID: 37273347
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
[TBL] [Abstract][Full Text] [Related]
4. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract][Full Text] [Related]
5. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.
Bandyopadhyay A; Ghosh AK; Chhatui B; Das D
Rep Pract Oncol Radiother; 2021; 26(2):170-178. PubMed ID: 34211766
[TBL] [Abstract][Full Text] [Related]
7. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
8. GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis.
Dharnipragada R; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
Neurooncol Adv; 2023; 5(1):vdad062. PubMed ID: 37324216
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
10. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
11. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters.
Chargari C; Mazeron R; Escande A; Maroun P; Dumas I; Martinetti F; Tafo-Guemnie A; Deutsch E; Morice P; Haie-Meder C
Brachytherapy; 2016; 15(4):456-462. PubMed ID: 27180129
[TBL] [Abstract][Full Text] [Related]
12. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
13. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
[TBL] [Abstract][Full Text] [Related]
14. Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
Imber BS; Young RJ; Beal K; Reiner AS; Giantini-Larsen AM; Krebs S; Yang JT; Aramburu-Nunez D; Cohen GN; Brennan C; Tabar V; Moss NS
J Neurooncol; 2022 Sep; 159(3):609-618. PubMed ID: 35896906
[TBL] [Abstract][Full Text] [Related]
15. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
[TBL] [Abstract][Full Text] [Related]
16. GammaTile® brachytherapy in the treatment of recurrent glioblastomas.
Gessler DJ; Neil EC; Shah R; Levine J; Shanks J; Wilke C; Reynolds M; Zhang S; Özütemiz C; Gencturk M; Folkertsma M; Bell WR; Chen L; Ferreira C; Dusenbery K; Chen CC
Neurooncol Adv; 2022; 4(1):vdab185. PubMed ID: 35088050
[TBL] [Abstract][Full Text] [Related]
17. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
18. Tumor dose-volume response in image-guided adaptive brachytherapy for cervical cancer: A meta-regression analysis.
Mazeron R; Castelnau-Marchand P; Escande A; Rivin Del Campo E; Maroun P; Lefkopoulos D; Chargari C; Haie-Meder C
Brachytherapy; 2016; 15(5):537-42. PubMed ID: 27371991
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
